IL-6 Released from Hepatic Stellate Cells Promotes Glycolysis and Migration of HCC Through the JAK1/vWF/TGFB1 Axis

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Wu J, Yang S, Xu K, et al. Patterns and trends of liver cancer incidence rates in eastern and southeastern asian countries (1983-2007) and predictions to 2030. Gastroenterology. 2018;154(6):1719–1728. doi:10.1053/j.gastro.2018.01.033
   PubMed Web of Science ®Google Scholar
• Tumen D, Heumann P, Gulow K, et al. pathogenesis and current treatment strategies of hepatocellular carcinoma. Biomedicines. 2022;10(12):3202–3242. doi:10.3390/biomedicines10123202
   PubMed Web of Science ®Google Scholar
• Niu ZS, Wang WH, Niu XJ. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World J Gastroenterol. 2022;28(46):6433–6477. doi:10.3748/wjg.v28.i46.6433
   PubMed Web of Science ®Google Scholar
• Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308. doi:10.3389/fimmu.2023.1133308
   PubMedGoogle Scholar
• Liu P, Kong L, Liu Y, et al. A key driver to promote HCC: cellular crosstalk in tumor microenvironment. Front Oncol. 2023;13:1135122. doi:10.3389/fonc.2023.1135122
   PubMed Web of Science ®Google Scholar
• Filliol A, Saito Y, Nair A, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022;610(7931):356–365. doi:10.1038/s41586-022-05289-6
   PubMed Web of Science ®Google Scholar
• Barry AE, Baldeosingh R, Lamm R, et al. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol. 2020;8:709. doi:10.3389/fcell.2020.00709
   PubMed Web of Science ®Google Scholar
• Akkiz H. Emerging role of cancer-associated fibroblasts in progression and treatment of hepatocellular carcinoma. Int J Mol Sci. 2023;24(4):3941–3962. doi:10.3390/ijms24043941
   PubMed Web of Science ®Google Scholar
• Zhang R, Gao X, Zuo J, et al. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci. 2020;111(2):406–417. doi:10.1111/cas.14262
   PubMed Web of Science ®Google Scholar
• Li S, Hu X, Yu S, et al. Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG / miR‐506‐3p/ TGFB1 axis. Cancer Sci. 2022;114(2):504–520. doi:10.1111/cas.15605
   PubMed Web of Science ®Google Scholar
• Chen QT, Zhang ZY, Huang QL, et al. HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma. Nat Metab. 2022;4(10):1306–1321. doi:10.1038/s42255-022-00642-5
   PubMedGoogle Scholar
• Makino Y, Hikita H, Kodama T, et al. CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate hcc progression. Cancer Res. 2018;78(17):4902–4914. doi:10.1158/0008-5472.CAN-17-3844
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Hung CH, Chiang M, Tsai YC, He JT. Hepatic stellate cells enhance liver cancer progression by inducing myeloid-derived suppressor cells through interleukin-6 signaling. Int J Mol Sci. 2019;20(20):5079. doi:10.3390/ijms20205079
   PubMed Web of Science ®Google Scholar
• Hapach LA, Mosier JA, Wang W, Reinhart-King CA. Engineered models to parse apart the metastatic cascade. NPJ Precis Oncol. 2019;3(1):20–28. doi:10.1038/s41698-019-0092-3
   PubMedGoogle Scholar
• Patmore S, Dhami SPS, O’Sullivan JM. Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemost. 2020;18(10):2444–2456. doi:10.1111/jth.14976
   PubMed Web of Science ®Google Scholar
• A-j Y, Wang M, Wang Y, et al. Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma. Oncogenesis. 2018;7(1):12–25. doi:10.1038/s41389-017-0023-5
   PubMedGoogle Scholar
• Gu J, Qi Y, Lu Y, et al. Lung adenocarcinoma-derived vWF promotes tumor metastasis by regulating PHKG1-mediated glycogen metabolism. Cancer Sci. 2022;113(4):1362–1376. doi:10.1111/cas.15298
   PubMed Web of Science ®Google Scholar
• Colonne CK, Favaloro EJ, Pasalic L. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer. Healthcare. 2022;10(3):557–575. doi:10.3390/healthcare10030557
   Web of Science ®Google Scholar
• Liu L, Pan J, Wang H, et al. von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro. Biosci Rep. 2018;38(6):372–382. doi:10.1042/BSR20180372
   Google Scholar
• Liu Y, Wang X, Li S, et al. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. J Proteomics. 2014;106:99–112. doi:10.1016/j.jprot.2014.04.021
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao J, Yin Y, et al. The Role of IL-6 in fibrotic diseases: molecular and cellular mechanisms. Int J Biol Sci. 2022;18(14):5405–5414. doi:10.7150/ijbs.75876
   PubMed Web of Science ®Google Scholar
• Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8(11):1419–1454. doi:10.3390/cells8111419
   PubMed Web of Science ®Google Scholar
• Yan Y, Zeng J, Xing L, Li C. Extra- and intra-cellular mechanisms of hepatic stellate cell activation. Biomedicines. 2021;9(8):1014–1031. doi:10.3390/biomedicines9081014
   PubMed Web of Science ®Google Scholar
• Byrd K, Alqahtani S, Yopp AC, Singal AG. Role of multidisciplinary care in the management of hepatocellular carcinoma. Semin Liver Dis. 2021;41(1):1–8. doi:10.1055/s-0040-1719178
   PubMedGoogle Scholar
• Quiroz Reyes AG, Lozano Sepulveda SA, Martinez-Acuna N, et al. Cancer stem cell and hepatic stellate cells in hepatocellular carcinoma. Technol Cancer Res Treat. 2023;22:1–13. doi:10.1177/15330338231163677
   Web of Science ®Google Scholar
• Feng J, Li J, Wu L, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):126–145. doi:10.1186/s13046-020-01629-4
   PubMed Web of Science ®Google Scholar
• Liu C, Xu K, Liu J, et al. LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis. Biol Direct. 2023;18(1):15–30. doi:10.1186/s13062-023-00370-0
   PubMed Web of Science ®Google Scholar
• Yu Q, Dai W, Ji J, et al. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway. J Cell Mol Med. 2022;26(10):3031–3045. doi:10.1111/jcmm.17322
   PubMed Web of Science ®Google Scholar
• Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost. 2012;10(8):1646–1652. doi:10.1111/j.1538-7836.2012.04797.x
   PubMed Web of Science ®Google Scholar
• Pablo-Moreno JA, Serrano LJ, Revuelta L, Sanchez MJ, Liras A. The vascular endothelium and coagulation: homeostasis, disease, and treatment, with a focus on the von Willebrand factor and factors VIII and V. Int J Mol Sci. 2022;23(15):8283–8325. doi:10.3390/ijms23158283
   PubMed Web of Science ®Google Scholar
• O’Sullivan JM, Preston RJS, Robson T, O’Donnell JS. Emerging Roles for von Willebrand Factor in Cancer Cell Biology. Semin Thromb Hemost. 2018;44(2):159–166. doi:10.1055/s-0037-1607352
   PubMed Web of Science ®Google Scholar
• Qi Y, Chen W, Liang X, et al. Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction. J Hematol Oncol. 2018;11(1):117–134. doi:10.1186/s13045-018-0659-4
   PubMedGoogle Scholar